Results 161 to 170 of about 18,483 (234)

Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSA range

Prostate Cancer and Prostatic Diseases, 2008
D. Colleselli, J. Bektic, M. Mitterberger, G. Schaefer, O. Dalpiaz, G. Bartsch, W. Horninger, Alexandre E. Pelzer   +7 more
semanticscholar   +1 more source

Identification of prostate cancer by urinary DLX1/HOXC6 expression in Chinese population with prostate-specific antigen levels of 4-10 ng/mL. [PDF]

Sci Rep
Zhang D, Xu J, Wang J, Jiang J.
europepmc   +1 more source

A small step forward\u2026 - corporate governance rating 2003 for Polish listed companies [PDF]

, 2003
Dzierzanowski, Maciej, Przybylowski, Michal, Tamowicz, Piotr   +2 more
core  

Unveiling the potential of apigenin and kaempferol against colon cancer: an integrated network pharmacology and docking approach. [PDF]

Front Bioinform
Selvakumar A, Chandran PA, Shraddha S, Dharshini LCP, Perumal S, Karuppasamy R, Mandal AKA.   +6 more
europepmc   +1 more source

Developing an interpretable clinical-radiomics machine learning model using whole transition zone MRI analysis for improving diagnosis of transition zone prostate cancer. [PDF]

Front Oncol
Yang J, Jiang N, Zhang Y, Yang L, Xia L, Ren Y, Xu H, Li Z, Wang J, Cui F.   +9 more
europepmc   +1 more source

Association between platelet-to-lymphocyte ratio and high risk for prostate cancer among middle-aged and older US men. [PDF]

Sci Rep
Chang Y, Wang W, Tao J, Zheng Z, Zhou J.
europepmc   +1 more source

Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

ACS Chemical Neuroscience, 2010
Travis T Wager, Xinjun Hou, P. Verhoest, A. Villalobos   +3 more
semanticscholar   +1 more source

Machine learning approaches for predicting progression in hormone-sensitive prostate cancer patients. [PDF]

Front Oncol
Zhu B, Jiang H, Zhang C, Wang Q, Yang L, Yang H, Li R, Li J, Pang X, Zheng Y, Yan L, Wang Y, Bai Y.   +12 more
europepmc   +1 more source

Association of systemic inflammatory biomarkers with prostate cancer risk: a population-based (NHANES) and clinical validation study. [PDF]

Front Endocrinol (Lausanne)
Huang G, Xiao K, Lin S, Lu X.
europepmc   +1 more source

The role of microrna-346 in prostate cancer progression: Clinical significance and biomarker potential. [PDF]

J Med Biochem
Wang L, Wang Y, Tian L, Wang Z, Liu X, Cheng G.   +5 more
europepmc   +1 more source